लोड हो रहा है...
A case report of disappearing pigmented skin lesions associated with pembrolizumab treatment for metastatic melanoma
Pembrolizumab is an immune checkpoint inhibitor that targets the programmed cell death (PD)-1 receptor. Common cutaneous adverse side effects of PD-1 inhibitors include maculopapular rash, pruritus, vitiligo, and lichenoid skin and mucosal reactions. Here, we describe a man in his sixties with metas...
में बचाया:
| में प्रकाशित: | Br J Dermatol |
|---|---|
| मुख्य लेखकों: | , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2017
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5533648/ https://ncbi.nlm.nih.gov/pubmed/28132411 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjd.15354 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|